Announcements Trials
Browse Landscape

Status

Temporarily not available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma, Ewing 1Prostatic Neoplasms, Castration-Resistant 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Myelodysplastic Syndromes 1Locally Advanced Pancreatic Adenocarcinoma 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1KRAS G12V Mutant Advanced Epithelial Cancers 1Hematologic Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 1Insulin Infusion Systems 1Gemcitabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Temporarily not available × KRAS G12V Mutant Advanced Epithelial Cancers × Clear all
NCT05389514 2025-11-20

Intermediate-size IND for Treatment of KRAS G12V-mutant Tumors

Providence Health & Services

Temporarily not available

KRAS G12V Mutant Advanced Epithelial Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡